Akso Health (AHG) Cost of Revenue (2017 - 2019)

Akso Health (AHG) has 3 years of Cost of Revenue data on file, last reported at $2.2 million in Q3 2019.

• Quarterly Cost of Revenue rose 2.04% year-over-year to $2.2 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $8.3 million (down 6.22% YoY) and the FY2026 annual result came in at $13.8 million, down 8.08% from the prior year.
• Cost of Revenue improved to $2.2 million in Q3 2019, from $1.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.2 million in Q4 2017 to a low of $1.3 million in Q2 2017.
• A 3-year average of $2.0 million and a median of $2.1 million in 2018 frame the typical range for Cost of Revenue.
• The widest YoY moves for Cost of Revenue: up 14.52% in 2018, down 29.91% in 2018.
• Tracing AHG's Cost of Revenue over 3 years: stood at $3.2 million in 2017, then retreated by 29.91% to $2.2 million in 2018, then decreased by 1.1% to $2.2 million in 2019.
• The last three Cost of Revenue figures came in at $2.2 million (Q3 2019), $1.6 million (Q1 2019), and $2.2 million (Q4 2018), per Business Quant data.